0001022079-21-000113.txt : 20210728 0001022079-21-000113.hdr.sgml : 20210728 20210728161833 ACCESSION NUMBER: 0001022079-21-000113 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210727 FILED AS OF DATE: 20210728 DATE AS OF CHANGE: 20210728 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILENSKY GAIL R CENTRAL INDEX KEY: 0001018538 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 211122760 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS STREET 2: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 4 1 wf-form4_162750349054685.xml FORM 4 X0306 4 2021-07-27 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001018538 WILENSKY GAIL R 500 PLAZA DRIVE SECAUCUS NJ 07094 1 0 0 0 Common Stock 2021-07-27 4 M 0 6111 57.565 A 23956 D Common Stock 2021-07-27 4 S 0 6111 139.323 D 17845 D Common Stock 2021-07-27 4 M 0 6111 61.225 A 23956 D Common Stock 2021-07-27 4 S 0 6111 139.268 D 17845 D Common Stock 13375 I by Trust Stock Options (Right to Buy) 57.565 2021-07-27 4 M 0 6111 57.565 D 2022-05-11 Common Stock 6111.0 0 D Stock Options (Right to Buy) 61.225 2021-07-27 4 M 0 6111 61.225 D 2023-05-21 Common Stock 6111.0 0 D This transaction was executed in multiple trades at prices ranging from $139.28 to $139.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $139.26 to $139.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The options vested in three annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015. The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016. William J. O'Shaughnessy, Jr., Attorney in Fact for Gail R. Wilensky 2021-07-28